W
Wendy Wieland-Alter
Researcher at Dartmouth–Hitchcock Medical Center
Publications - 37
Citations - 1245
Wendy Wieland-Alter is an academic researcher from Dartmouth–Hitchcock Medical Center. The author has contributed to research in topics: Antibody & Poliovirus. The author has an hindex of 18, co-authored 34 publications receiving 882 citations. Previous affiliations of Wendy Wieland-Alter include Dartmouth College & Muhimbili University of Health and Allied Sciences.
Papers
More filters
Journal ArticleDOI
Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
Mrunal Sakharkar,C. Garrett Rappazzo,Wendy Wieland-Alter,Ching-Lin Hsieh,Daniel Wrapp,Emma S. Esterman,Chengzi I. Kaku,Anna Z. Wec,James C. Geoghegan,Jason S. McLellan,Ruth I Connor,Peter F. Wright,Laura M. Walker +12 more
TL;DR: In this article, the authors studied the human B cell response to SARS-CoV-2 infection in mild and severe COVID-19 patients over a period of five months.
Journal ArticleDOI
Prevalence of Toxic Shock Syndrome Toxin 1-Producing Staphylococcus aureus and the Presence of Antibodies to This Superantigen in Menstruating Women
Jeffrey Parsonnet,Melanie A. Hansmann,Mary L. Delaney,Paul A. Modern,Andrea M. DuBois,Wendy Wieland-Alter,Kimberly W. Wissemann,John E. Wild,Michaelle B. Jones,Jon L. Seymour,Andrew B. Onderdonk +10 more
TL;DR: It is demonstrated that the majority of teenagers have antibody titers (≥1:32) to TSST-1 and are presumed to be protected from mTSS, and the findings suggest that black women may be more susceptible to m TSS than previously thought.
Journal ArticleDOI
Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors.
Jeffrey M. Bergelson,John F. Modlin,Wendy Wieland-Alter,Jennifer Cunningham,Richard L. Crowell,Robert W. Finberg +5 more
TL;DR: Interactions between low-passage clinical coxsackie B virus isolates and the two receptors indicate that receptor use by clinical isolates is not strictly related to serotype and that even prototype strains with different passage histories may differ in receptor use.
Journal ArticleDOI
Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.
Sinthujan Jegaskanda,Catherine J. Luke,Heather D. Hickman,Mark Y. Sangster,Wendy Wieland-Alter,Jacqueline McBride,J W Yewdell,Peter F. Wright,John J. Treanor,Carrie M. Rosenberger,Kanta Subbarao +10 more
TL;DR: ADCC-Ab titers increased following experimental influenza virus infection in adults and after ISV administration in both children and adults.
Journal ArticleDOI
A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals
Rafal S. Sobota,Rafal S. Sobota,Catherine M. Stein,Nuri Kodaman,Nuri Kodaman,Nuri Kodaman,Laura B. Scheinfeldt,Laura B. Scheinfeldt,Isaac Maro,Wendy Wieland-Alter,Robert P. Igo,Albert Magohe,LaShaunda L. Malone,Keith A. Chervenak,Noemi B. Hall,Chawangwa Modongo,Chawangwa Modongo,Nicola M. Zetola,Nicola M. Zetola,Mecky Matee,Moses Joloba,Moses Joloba,Alain Froment,Thomas B. Nyambo,Jason H. Moore,Jason H. Moore,William K. Scott,Timothy Lahey,W. Henry Boom,C. Fordham von Reyn,Sarah A. Tishkoff,Giorgio Sirugo,Scott M. Williams,Scott M. Williams +33 more
TL;DR: The results suggest that HIV-positive individuals who do not develop TB, despite living in areas where it is hyperendemic, provide a model of natural resistance and suggest that this pathway might be an excellent target for the development of new modalities for treating TB, especially for HIV- positive individuals.